Jason Kelly
Vermögen: 22 Mio $ am 31.05.2026
Vermögen: 22 Mio $ am 31.05.2026
Jason Kelly gründete Ginkgo Bioworks Holdings, Inc. und Ginkgo Bioworks, Inc. Derzeit ist er Chief Executive Officer & Director bei Ginkgo Bioworks Holdings, Inc. und Chief Executive Officer & Director bei Ginkgo Bioworks, Inc. (eine Tochtergesellschaft von Ginkgo Bioworks Holdings, Inc.). Dr. Kelly ist auch Mitglied des Vorstands von Octant, Inc. und Motif Food Works, Inc. In seiner früheren Laufbahn war Dr. Kelly Chief Executive Officer & Director bei Soaring Eagle Acquisition Corp. Er erwarb einen Bachelor-Abschluss und einen Doktortitel am Massachusetts Institute of Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2026 | 2 041 437 ( 22,21 % ) | 19 Mio $ | 31.05.2026 | |
| 15.04.2026 | 316 483 ( 0,59 % ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Gründer | 01.01.2008 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Gründer | 01.01.2008 |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Direktor/Vorstandsmitglied | - |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktor/Vorstandsmitglied | - |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Direktor/Vorstandsmitglied | - |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Private Equity Investor | - |
| Unternehmen | Position | Ende |
|---|---|---|
| STANDARD BIOTOOLS INC. | Direktor/Vorstandsmitglied | 01.09.2021 |
| GINO BIOW | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Consumer Non-Durables |
CM Life Sciences II, Inc.
CM Life Sciences II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen